Abstract
B-cell lymphoproliferative disorders are rare but serious complications of solid organ and bone marrow transplantation. We report that these tumors frequently express the CD-20 antigen, and immunotherapy directed at this antigen may be a well-tolerated and effective treatment. (C) 2000 Wiley-Liss, Inc.
| Original language | English |
|---|---|
| Pages (from-to) | 171-173 |
| Number of pages | 3 |
| Journal | American Journal of Hematology |
| Volume | 65 |
| Issue number | 2 |
| DOIs | |
| State | Published - Oct 5 2000 |
| Externally published | Yes |
Fingerprint
Keywords
- CD-20
- Post-transplant lymphoproliferative disorder
- PTLD
- Rituximab
ASJC Scopus subject areas
- Hematology
Cite this
CD-20 expression in post-transplant lymphoproliferative disorders : Treatment with rituximab. / Ifthikharuddin, J. J.; Mieles, L. A.; Rosenblatt, Joseph D; Ryan, C. K.; Sahasrabudhe, D. M.
In: American Journal of Hematology, Vol. 65, No. 2, 05.10.2000, p. 171-173.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - CD-20 expression in post-transplant lymphoproliferative disorders
T2 - Treatment with rituximab
AU - Ifthikharuddin, J. J.
AU - Mieles, L. A.
AU - Rosenblatt, Joseph D
AU - Ryan, C. K.
AU - Sahasrabudhe, D. M.
PY - 2000/10/5
Y1 - 2000/10/5
N2 - B-cell lymphoproliferative disorders are rare but serious complications of solid organ and bone marrow transplantation. We report that these tumors frequently express the CD-20 antigen, and immunotherapy directed at this antigen may be a well-tolerated and effective treatment. (C) 2000 Wiley-Liss, Inc.
AB - B-cell lymphoproliferative disorders are rare but serious complications of solid organ and bone marrow transplantation. We report that these tumors frequently express the CD-20 antigen, and immunotherapy directed at this antigen may be a well-tolerated and effective treatment. (C) 2000 Wiley-Liss, Inc.
KW - CD-20
KW - Post-transplant lymphoproliferative disorder
KW - PTLD
KW - Rituximab
UR - http://www.scopus.com/inward/record.url?scp=0033828581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033828581&partnerID=8YFLogxK
U2 - 10.1002/1096-8652(200010)65:2<171::AID-AJH14>3.0.CO;2-Z
DO - 10.1002/1096-8652(200010)65:2<171::AID-AJH14>3.0.CO;2-Z
M3 - Article
C2 - 10996837
AN - SCOPUS:0033828581
VL - 65
SP - 171
EP - 173
JO - American Journal of Hematology
JF - American Journal of Hematology
SN - 0361-8609
IS - 2
ER -